Trials Data on COPD Leave Primary Care Docs in the Dark : vi

Flare-ups and breathing difficulties were common among patients seen at primary care practices, suggesting a need for better evidence to guide treatment for the condition, a new analysis found.

Related Keywords

United States , Illinois , Ann Arbor , Michigan , Houston , Texas , Baylor College Of Medicine , Americans , American , Jerry Krishnan , Meilan Han , Nicola Hanania , Glaxosmithkline , Amgen , National Health , Genentech , Boehringer Ingelheim , Novartis , University Of Michigan , Department Of Family , Division Of Pulmonary , Pfizer , Astrazeneca , University Of Minnesota , Dartnet Institute , Centers For Disease , University Of Illinois Chicago , Drug Administration , American Lung Association , Johnson , Community Health , Novo Nordisk , Critical Care , Medscape Medical , Barbara Yawn , Window Onto Patient Burden , Disease Control , Family Medicine , Patient Experience , Illinois Chicago , Airways Clinical Research Center , Baylor College , Nutrition Examination Surveys , Optimum Patient Care Global , Chronic Obstructive Pulmonary Disease Copd , Chronic Obstructive Pulmonary Disease , Copd , Chronic Obstructive Lung Disease , Dyspnea , Hypertension , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Physical Medicine And Rehabilitation , Hysiatry , Primary Care , Pulmonary Rehabilitation , Weha ,